Ausgabe 3/1999
Inhalt (8 Artikel)
Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype
Jose M. Garcia, Jose M. Silva, Gemma Dominguez, Rocio Gonzalez, Antonia Navarro, Luis Carretero, Mariano Provencio, Pilar España, Felix Bonilla
Biomarkers for local recurrence after breast‐conservation — a nested case‐control study
K. Dalberg, E. Eriksson, L. Kanter, K. Sandelin, A. Liedberg, G. Auer, S. Thorstensson, I. Fredriksson, U. Johansson, L.E. Rutqvist
Anti‐human procathepsin D activation peptide antibodies inhibit breast cancer development
Vaclav Vetvicka, Jana Vetvickova, Martin Fusek
Antimetastatic effect of desmopressin in a mouse mammary tumor model
Daniel F. Alonso, Guillermo Skilton, Eduardo F. Farías, Elisa Bal de Kier Joffé, Daniel E. Gomez
Tamoxifen and fenretinide in women with metastatic breast cancer
J. Zujewski, L. Pai, L. Wakefield, R. Giusti, F.A. Dorr, C. Flanders, R. Caruso, M. Kaiser, L. Goodman, M. Merino, M. Gossard, M.A. Noone, A. Denicoff, D. Venzon, K.H. Cowan, J.A. O'Shaughnessy
Changes in body composition during breast cancer chemotherapy with the CMF‐regimen
A. Aslani, R.C. Smith, B.J. Allen, N. Pavlakis, J.A. Levi